Viridian Therapeutics (VRDN) P/E (2014 - 2026)
Viridian Therapeutics (VRDN) P/E from Jun 30, 2014 to Jul 21, 2026. The TTM Viridian Therapeutics (VRDN) P/E is -4.97. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Viridian Therapeutics (VRDN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.97 | -37.71% |
| 2025 | -7.98 | +55.24% |
| 2024 | -5.14 | +19.03% |
| 2023 | -4.32 | -40.33% |
| 2022 | -7.23 | +140.52% |
| 2021 | -3.01 | +393.17% |
| 2020 | -0.61 | +87.27% |
| 2019 | -0.33 | -84.16% |
| 2018 | -2.06 | -70.95% |
| 2017 | -7.08 | +32.88% |
| 2016 | -5.32 | -40.56% |
| 2015 | -8.96 | -55.33% |
| 2014 | -20.05 | N/A |
Comparison Viridian Therapeutics (VRDN) P/E with competitors
Viridian Therapeutics (VRDN) P/E is -4.97.